European buy-rated stocks that trade cheaply vs. their U.S. peers - UBS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 11 2024
0mins
Source: SeekingAlpha
- UBS Analysts' European Stock Recommendations: UBS analysts highlight European stocks that are considered superior to their U.S. peers and trade cheaply relative to their norm.
- List of European Stocks: The list includes companies like Mercedes-Benz Group AG, Nestle SA, Heineken NV, Novartis, and more, with their 12-month forward PE ratios compared to U.S. peers.
- Unique European Buy-Rated Stocks: Some European stocks like Orsted AS, Cie Financiere Richemont SA, Andritz, and Krones are unique relative to peers and trade cheaply compared to their historical averages.
- STOXX Europe 600 Index News: The article also mentions the Dollar's softness ahead of the Employment Report, Japan's impact on the Yen, EMU GDP growth, reasons to prefer the European market over the U.S., and top names with expensive earnings volume for the season according to Barclays.
Analyst Views on HLN
Wall Street analysts forecast HLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLN is 13.44 USD with a low forecast of 13.44 USD and a high forecast of 13.44 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 10.330
Low
13.44
Averages
13.44
High
13.44
Current: 10.330
Low
13.44
Averages
13.44
High
13.44
About HLN
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
